Thioredoxin-Interacting Protein as a Novel Potential Therapeutic Target in Diabetes Mellitus and Its Underlying Complications
Dawit Zewdu Wondafrash,1 Asmelash Tesfay Nire’a,2 Gebrehiwot Gebremedihn Tafere,1 Desilu Mahari Desta,3 Demoze Asmerom Berhe,4 Kaleab Alemayehu Zewdie1 1Department of Pharmacology and Toxicology, School of Pharmacy, Mekelle University, Mekelle, Ethiopia; 2Pharmacology and Toxicology Resear...
Main Authors: | Wondafrash DZ, Nire'a AT, Tafere GG, Desta DM, Berhe DA, Zewdie KA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-01-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Subjects: | |
Online Access: | https://www.dovepress.com/thioredoxin-interacting-protein-as-a-novel-potential-therapeutic-targe-peer-reviewed-article-DMSO |
Similar Items
-
Role of Thioredoxin-Interacting Protein in Diseases and Its Therapeutic Outlook
by: Naila Qayyum, et al.
Published: (2021-03-01) -
Thioredoxin-interacting protein in diabetic retinal neurodegeneration: A novel potential therapeutic target for diabetic retinopathy
by: Chengzhi Liu, et al.
Published: (2022-08-01) -
Thioredoxin/Txnip: Redoxisome, As a Redox Switch for the Pathogenesis of Diseases
by: Eiji eYoshihara, et al.
Published: (2014-01-01) -
Verapamil Ameliorates Hepatic Metaflammation by Inhibiting Thioredoxin-Interacting Protein/NLRP3 Pathways
by: Feng Zhou, et al.
Published: (2018-10-01) -
A Fluorine-19 Magnetic Resonance Probe, Shiga-Y5, Downregulates Thioredoxin-Interacting Protein Expression in the Brain of a Mouse Model of Alzheimer’s Disease
by: Aslina Pahrudin Arrozi, et al.
Published: (2021-09-01)